Related Experiment Video
Updated: Jan 29, 2026

08:49
Models of Bone Metastasis
Published on: September 4, 2012
43.1K
[Radiotherapy for Bone Metastasis after Esophageal Cancer Surgery]
Seiichi Nakaya1, Hideyuki Ishiguro, Shiro Fujihata
1Dept. of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|February 16, 2019
Summary
Radiotherapy can effectively treat bone metastasis in esophageal cancer patients, reducing metastatic lesions and relieving pain. This study highlights radiation therapy
Area of Science:
- Oncology
- Radiation Oncology
- Surgical Oncology
Background:
- Esophageal cancer frequently metastasizes to bone, impacting patient prognosis and quality of life.
- Postoperative management of bone metastasis after esophageal cancer surgery requires effective treatment strategies.
Purpose of the Study:
- To evaluate the efficacy of radiotherapy in managing bone metastases following surgical resection of esophageal cancer.
- To assess the impact of radiation therapy on metastatic lesion reduction and pain improvement in this patient cohort.
Main Methods:
- Retrospective analysis of 11 patients with postoperative bone metastases from esophageal cancer (2001-2016).
- Seven patients received radiotherapy for bone metastasis; data on lesion response and pain relief were collected.
- Patient demographics, cancer histology, metastatic sites, and concurrent treatments (chemotherapy) were recorded.
Main Results:
- Of 7 patients treated with radiotherapy, 4 (57%) demonstrated a reduction in metastatic bone lesions.
- A 57% pain improvement rate was observed in patients receiving radiation therapy for bone metastasis.
- Common metastatic sites included vertebral bodies, ribs, skull, ilium, humerus, and femur.
Conclusions:
- Radiotherapy is a potentially effective treatment for bone metastasis in esophageal cancer patients.
- Radiation therapy can lead to significant reduction of metastatic lesions and provide substantial pain relief.
- Further investigation into optimal radiotherapy protocols for esophageal cancer bone metastasis is warranted.
Related Concept Videos
Metastasis
6.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.6K
Esophageal Varices-I: Introduction
1.4K
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.4K
Esophageal Perforation-I: Introduction
591
Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
591
Esophageal Strictures-I: Introduction
853
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
853
Esophageal Strictures-II: Clinical Features and Management
605
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
605
Esophageal Perforation-II: Clinical Manifestations and Management
715
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
715

